tiprankstipranks
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
2616
CStone Pharmaceuticals
RESEARCH TOOLSreports

CStone Pharmaceuticals (2616) Stock News & Sentiment

4 Followers
CStone’s 2025 Loss Widens as R&D Spend Climbs Ahead of Pralsetinib NRDL Boost
Premium
Company Announcements
CStone’s 2025 Loss Widens as R&D Spend Climbs Ahead of Pralsetinib NRDL Boost
19d ago
2616
CStone Fast-Tracks Global Phase III Plan After Strong Early Data for Trispecific Cancer Antibody CS2009
Premium
Company Announcements
CStone Fast-Tracks Global Phase III Plan After Strong Early Data for Trispecific Cancer Antibody CS2009
19d ago
2616
CStone’s Sugemalimab Wins Top ESMO Backing for Stage III Lung Cancer
Premium
Company Announcements
CStone’s Sugemalimab Wins Top ESMO Backing for Stage III Lung Cancer
20d ago
2616
CStone to Showcase Three ADC Pipeline Programs at 2026 AACR Meeting
Premium
Company Announcements
CStone to Showcase Three ADC Pipeline Programs at 2026 AACR Meeting
28d ago
2616
CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
Premium
Company Announcements
CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
2M ago
2616
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
Premium
Company Announcements
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
2M ago
2616
CStone Pharmaceuticals Streamlines Company Secretary and Authorized Representative Roles
Premium
Company Announcements
CStone Pharmaceuticals Streamlines Company Secretary and Authorized Representative Roles
2M ago
2616
More HK:2616 News >

2616 News on the Web

Goldman Sachs Sticks to Its Buy Rating for CStone Pharmaceuticals (2616)
TipRanks News
Neutral
CStone’s 2025 Loss Widens as R&D Spend Climbs Ahead of Pralsetinib NRDL Boost
TipRanks News
Neutral
CStone Fast-Tracks Global Phase III Plan After Strong Early Data for Trispecific Cancer Antibody CS2009
TipRanks News
Bullish
CStone’s Sugemalimab Wins Top ESMO Backing for Stage III Lung Cancer
TipRanks News
Bullish
CStone to Showcase Three ADC Pipeline Programs at 2026 AACR Meeting
TipRanks News
Bullish
Guoyuan Securities (HK) Reaffirms Their Buy Rating on CStone Pharmaceuticals (2616)
TipRanks News
Neutral
CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
TipRanks News
Bullish
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2616’s Media Buzz Sentiment?
Currently, no data Available
What is HK:2616’s weekly average amount of articles?
Currently, no data Available
What is HK:2616’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
ALLOAllogene Therapeutics
STAAStaar Surgical
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week